Clinical Observation On CAIR Capsule In The Treatment Of Hydrocephalus At Acute Stage After Cerebral Hemorrhagic Stroke

ObjectiveThe clinical efficacy of CAIR(inducing resuscitation for cerebral arteries) capsule in the treatment of hydrocephalus at acute stage after cerebral hemorrhagic stroke was observed. The clinical trial supported the treatment of hydrocephalus at acute stage after cerebral hemorrhagic stroke.MethodsAccording to table of random numbers,60 standardized patients with acute cerebral hemorrhagic were divided into treatment group and control group, both cases of which consisted of 30 patients. The western standard treatment of clinical path was involved in both groups. Meanwhile, the treatment method that was purgating fu-organs to eliminate heat and expelling blood stasis and eliminating phlegm for resuscitation, was involved in treatment group, whose members took CAIR capsule and the period of treatment was 14 daysAll patients of both groups who out broke of this diseased within 24 hours, 7 days or 14 days, were observed and compared in accordance with the score of neurologic impairment as well as haematoma and absorbing state of peripheral edema was examine by CT. The variable me;in rate of hydrocephalus was calculated and statistical comparison and analysis was performed.Results1. The cerebral hemorrhage volume, peripheral edema and different score of neurologic impairment of patients in prior treatment have no statistical significance but are comparable.2. After 7 days and 14 days treatment peroil, the haematoma volume of patients in both groups decreased. The haematoma volume of treatment group decreased more evidently than control group. The absorbing state of cerebral hemorrhage of both groups was effeetive. What’s more, the effect of treatment group was better than the control group. There was statistical significance in comparison with both groups, (average P<0.05)3. After 7 days treatment period, the hydrocephalus of patients of both groups increased than before. The control group was more evident than treatment group. There was statistical significance in comparison with both groups. (P<0.05) The tendency of the cerebral edema delayed of treatment group was more effective than the control group. After 14 days treatment period, the absorbing state of hydrocephalus of patients in both groups decreased. But there was no significant difference between two groups (P> 0.05), and it was not comparable. Whether CAIR capsule was effective on the absorbing state of hydrocephalus could not be confirmed. After 7 days treatment period, there was statistical significance for the variable mean rate of hydrocephalus of two groups (P<0.05). After 14 days treatment period, there was not statistical significance of the variable mean rate of two groups (P>0.05). The variable mean rate in the early days (within 7 days), could give response to the tendency of the cerebral edema.4. After 7 days treatment period, the standard score of patients in both groups did not decrease obviously. There was not statistical significance in comparison with both groups (P>0.05). The neurologic impairment of patients in early days (within 7 days) was not improved obviously. After 14 clays treatment period, the standard score of patients in both groups decreased respectively. There was statistical significance in comparison with both groups (P<0.05). After 14 days treatment period, the neurologic impairment of treatment group was improved better than the control group.5. There was no obviously untoward effect on the patients in both groups in the process of treatment, which indicated clinical efficacy of CAIR capsule was safe.ConclusionThe efficacy of CAIR capsule is purgating fu-organs to eliminate heat and expelling blood stasis and eliminating phlegm for resuscitation. The neurologic impairment of consciousness, language and pantomime of patients can be improved after took CAIR capsule, combined with western medicine with comprehensive treatment. The mechanism may delay the progress of cerebral edema by promoting the absorption of haematoma in the early -stage (within 7 days). The aggravated peripheral hydrocephalus was inhibited and mass effect was reduced. Therefore, the neurologic impairment of consciousness, language and pantomime of patients can be alleviated. CAIR capsule in the treatment of hydrocephalus at acute stage after cerebral hemorrhagic stroke is worth popularizing because it is safe and reliable in clinical trial.